PATENT CLAIM ANALYSIS

Application Number: 16288650
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["424", "001890"]

Abstract:
The present invention provides a pharmaceutical composition comprising [ 18 F]FACBC having certain advantages over known compositions comprising [ 18 F]FACBC. Also provided by the present invention is a method to obtain the composition of the invention.

Claim (Index 22):
A positron emission tomography (PET) tracer composition comprising anti-1-amino-3- 18 F-fluorocyclobutyl-1-carboxylic acid ( 18 F-FACBC) having an end of synthesis (EOS) radioactive concentration (RAC) of at least 1,000 MBq/mL, and comprising no more than 150 \u03bcg/mL hydroxyl-ACBC, wherein the composition is prepared without passing the reaction mixture through an alumina solid phase.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 99.0
- Lexical Diversity: 1.48276
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14780900', '14420493', '15318122', '11425078', '15526245']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7208324243249098
- 35 USC 102 Novelty (BERT): 0.5153595973693628
- Combined Prediction Score: 0.7002851416293551
- Mean Citation Score: 213.502784
- Max Citation Score: 274.436
- Similarity Product: 174.2776697962284

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test